4.5 Article

Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients - calculated sample size: 1816 patients

Related references

Note: Only part of the references are listed.
Editorial Material Medicine, General & Internal

Will procalcitonin reduce antibiotic use in intensive care?

Marin H. Kollef

LANCET (2010)

Article Respiratory System

Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study

D. Stolz et al.

EUROPEAN RESPIRATORY JOURNAL (2009)

Article Critical Care Medicine

Use of procalcitonin to shorten antibiotic treatment duration in septic patients - A randomized trial

Vandack Nobre et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)

Review Critical Care Medicine

Pyocalcitonin assay in systemic inflammation, infection, and sepsis: Clinical utility and limitations

Kenneth L. Becker et al.

CRITICAL CARE MEDICINE (2008)

Article Critical Care Medicine

The influence of corticosteroids on the release of novel biomarkers in human endotoxemia

Martijn D. de Kruif et al.

INTENSIVE CARE MEDICINE (2008)

Review Infectious Diseases

Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis

Benjamin M. P. Tang et al.

LANCET INFECTIOUS DISEASES (2007)

Article Critical Care Medicine

Cost of Gram-negative resistance

Heather L. Evans et al.

CRITICAL CARE MEDICINE (2007)

Article Critical Care Medicine

Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia a Randomized trial

Miriam Christ-Crain et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)

Article Critical Care Medicine

Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit

B Müller et al.

CRITICAL CARE MEDICINE (2000)